Natera's Signatera outperforms AMERK in skin cancer recurrence study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. USO
2. DHR
3. NVDA
4. SPY
5. AMD
6. GM
7. SMCI
8. GOOGL
9. TSLA
10. NOW

Go back to Natera's Signatera outperforms AMERK in skin cancer recurrence study
(NASDAQ: NTRA) Delayed: 264.22 -2.96 (1.11%)
Previous Close $267.18    52 Week High $13.80 
Open $263.38    52 Week Low $6.52 
Day High $266.00    P/E N/A 
Day Low $257.84    EPS $0.00 
Volume 806,867